Visit us at Festival of Biologics in Basel Oct. 15-17, 2019
Fast, accurate and reproducible quantification of IgG in fermentation media, plasma, serum etc.
Quantitative, in-solution validation of Kd data
Unique and precise size-based characterization and quantification of vesicles such as exosomes and liposomes
Come by booth #52 also if you are just curious to learn about our direct, in-solution quantification and characterization of proteins etc.
Or at NextGen Biophysics, Nov. 8, in Cambridge, UK, at PEGS Europe, Nov. 18-22 in Lisbon, at NextGen Protein Analysis & Detection, Dec. 3 at VIB in Ghent, at PepTalk, Jan. 20-24, 2020, in San Diego, and at SLAS, Jan 25-29, 2020, also in San Diego.
Direct detection and quantification of proteins under native conditions
Mitigate immunogenicity with fast development of specific assays
Faster drug development – higher safety – better efficacy
Easy protocols – results in 5 min. – built-in quality control
Flow Induced Dispersion Analysis (FIDA) is a new proprietary technology developed for quantification and characterization of proteins (including biologics), and other molecules and particles from 0,5 -1.000 nm, incl. affinity, concentration, absolute size and viscosity determination. FIDA is characterized by being fast (minutes), requiring very small sample amounts (nL-mL), and being exceptionally tolerant to the sample matrix. Contrary to most other procedures, the FIDA methodology is based on binding in homogenous solutions; complications related to non-specific surface adsorption and challenging assay development are therefore avoided. The unique features of FIDA enable characterization and quantification in native (biorelevant) environments and in-built assay quality control and automation.